EMFAT
CBAY

Emerald Mutual Fund Advisers Trust’s Cymabay Therapeutics CBAY Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-878,275
Closed -$20.7M – 260
2023
Q4 		$20.7M Buy
878,275
+68,537
+8% +$1.22M 1.1% 27
2023
Q3 		$12.1M Buy
+809,738
New +$10.7M 0.73% 61

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's CBAY Position: Q1 2024 in Review

Emerald Mutual Fund Advisers Trust sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 878,275 shares — an estimated $20.7M sold.

Emerald Mutual Fund Advisers Trust first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $20.7M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Emerald Mutual Fund Advisers Trust reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 878,275 Cymabay Therapeutics shares in Q1 2024, an estimated $20.7M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Emerald Mutual Fund Advisers Trust's Cymabay Therapeutics position peaked at $20.7M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2024, filed 8 May 2024.